Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients

Completed · Phase 3

Conditions studied: Lymphoma

In brief

The goal of this clinical research study is to compare chemotherapy given with rituximab to chemotherapy followed by rituximab. The safety of both treatment schedules will be studied. Laboratory tests of genetic changes in blood and bone marrow before and during the study will also be monitored.

Key facts

Study ID

NCT00577993

Run by

M.D. Anderson Cancer Center

People needed

210

Starts

1998-03-16

Expected to finish

2017-08-24

Last updated by the study team

2020-11-16

Who can join

Age: any, up to 76. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Previously untreated stage IV indolent B-cell lymphoma [Amendment May 2001: eligibility restricted to follicular lymphoma]
• Age <76

You may not qualify if…

• N/A

Where it is running

• University of Texas MD Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.